1-5 of 5
recombinant human pentraxin 2
Close
Sort by
Journal Articles

SLAMF7 high CD16 negative Monocytes Increase in Peripheral Blood of Patients with Myelofibrosis in Correlation with JAK2V617F Mutation

Takaaki Maekawa, MD, Shoichiro Kato, MD, Yosuke Okada, MD, Noriaki Tachi, MD, Masahiro Teramoto, MD, Toshikuni Kawamura, MD, Yukiko Osawa, PhD, Shinichi Kobayashi, MD PhD, Ken Sato, MD PhD, Michihiro Hashimoto, PhD, Shinya Suzu, PhD, Kensuke Usuki, MD PhD, Soji Morishita, PhD, Marito Araki, PhD, Norio Komatsu, MD PhD, Fumihiko Kimura, Prof, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4330.
https://doi.org/10.1182/blood-2018-99-110916
Published: 2018
Journal Articles

Beyond JAK2 Inhibitors: A Systematic Review of Management Strategies for Myelofibrosis

Ali Younas Khan, MD, Nimra Iftikhar, MD, Awais Ijaz, MD, Muhammad Junaid Tariq, MD, Faiza Jamil, MD, Arshia Akbar, MD, Anum Qureshi, Jemin Aby Jose, MD, Ahmad Kamal, MD, Muhammad Abu Zar, MD, Madeeha Shafqat, Insija Ilyas Selene, MBBS, Shehroz Aslam, MD, Faiz Anwer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5484.
https://doi.org/10.1182/blood-2018-99-115867
Published: 2018
Journal Articles

PRM-151 in Myelofibrosis: Efficacy and Safety in an Open Label Extension Study

Srdan Verstovsek, MD PhD, Robert P. Hasserjian, MD, Olga Pozdnyakova, MD PhD, Ivo Veletic, MD, Ruben A. Mesa, MD, Lynda Foltz, MD FRCPC, John Mascarenhas, MD, Ellen K. Ritchie, MD, Jeanne Palmer, MD, Richard T. Silver, MD, Marina Kremyanskaya, MD PhD, Bernt van den Blink, MD PhD, Renu Gupta, MD, Taghi Manshouri, PhD, C. Cameron Yin, MD PhD, Zeev E. Estrov, MD, Jason R. Gotlib, MDMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 686.
https://doi.org/10.1182/blood-2018-99-115362
Published: 2018
Journal Articles

PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks

Srdan Verstovsek, MD, Ruben A. Mesa, Lynda M Foltz, MD, Vikas Gupta, MD MRCP, MRCPath, John O. Mascarenhas, MD MS, Ellen K. Ritchie, MD, Ronald Hoffman, MD, Richard T. Silver, MD, Marina Kremyanskaya, MDPhD, Olga Pozdnyakova, MD, Robert P. Hasserjian, MD, Elizabeth Trehu, MD, Mohamed E Salama, MD, Hagop M Kantarjian, MD, Jason Gotlib, MD
Journal: Blood
Blood (2015) 126 (23): 56.
https://doi.org/10.1182/blood.V126.23.56.56
Published: 2015
Journal Articles

Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results

Srdan Verstovsek, MD PhD, Ruben A. Mesa, MD, Lynda M Foltz, MD, Vikas Gupta, MD FRCP, FRCPath, John O Mascarenhas, MD MS, Ellen K. Ritchie, MD, Ronald Hoffman, MD, Richard T. Silver, MD, Marina Kremyanskaya, MDPhD, Olga Pozdnyakova, MD PhD, Robert P Hasserjian, MD, Elizabeth Trehu, MD, Hagop M. Kantarjian, MD, Jason R. Gotlib, MD
Journal: Blood
Blood (2014) 124 (21): 713.
https://doi.org/10.1182/blood.V124.21.713.713
Published: 2014